Uncategorized
Intel Strengthens Ties with China, Invests $300 Million to Expand Chip Operations
Intel announces plans to expand chip packaging and testing facility in China despite cybersecurity review, highlights China as its largest market. read more
Novartis Q3 Earnings Beats Expectations On Strong Sales From Key Drugs, Lifts 2024 Outlook
Novartis reported strong third-quarter sales of $12.823 billion, beating consensus, with key growth drivers contributing to momentum and upgraded guidance for 2024. read more
The Analyst Verdict: TG Therapeutics In The Eyes Of 5 Experts
Latest Ratings for TGTX DateFirmActionFromTo Jan 2022HC Wainwright & Co.MaintainsBuy Jan 2022HC Wainwright & Co.MaintainsBuy Dec 2021Evercore ISI GroupMaintainsOutperform View More Analyst Ratings for TGTX View the Latest Analyst Ratings read more
Key Takeaways From Inari Medical Analyst Ratings
Latest Ratings for NARI DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022SVB LeerinkMaintainsOutperform Nov 2021SVB LeerinkMaintainsOutperform View More Analyst Ratings for NARI View the Latest Analyst Ratings
EXCLUSIVE: Matt Higgins Becomes First Investor On US And Dubai Shark Tank, Says UAE Fosters A ‘Culture Of Experimentation, Innovation’
Matt Higgins the first Shark to appear on Shark Tank versions in U.S. and Dubai. Here’s what drew the investor and entrepreneur to the UAE version of hit business show. read more
A Closer Look at 3 Analyst Recommendations For ThredUp
Latest Ratings for TDUP DateFirmActionFromTo Mar 2022Morgan StanleyMaintainsEqual-Weight Mar 2022Piper SandlerMaintainsOverweight Feb 2022Wells FargoMaintainsOverweight View More Analyst Ratings for TDUP View the Latest Analyst Ratings read more
Demystifying F5: Insights From 4 Analyst Reviews
Latest Ratings for FFIV DateFirmActionFromTo Feb 2022Loop CapitalInitiates Coverage OnBuy Jan 2022CitigroupMaintainsNeutral Jan 2022Credit SuisseMaintainsOutperform View More Analyst Ratings for FFIV View the Latest Analyst Ratings read more
Deep Dive Into Exact Sciences Stock: Analyst Perspectives (7 Ratings)
Latest Ratings for EXAS DateFirmActionFromTo Feb 2022Wells FargoMaintainsEqual-Weight Feb 2022CitigroupMaintainsNeutral Feb 2022Raymond JamesMaintainsOutperform View More Analyst Ratings for EXAS View the Latest Analyst Ratings read more
Expert Outlook: Calix Through The Eyes Of 4 Analysts
Latest Ratings for CALX DateFirmActionFromTo Feb 2022Loop CapitalInitiates Coverage OnBuy Jan 2022Craig-HallumUpgradesHoldBuy Oct 2021NeedhamMaintainsBuy View More Analyst Ratings for CALX View the Latest Analyst Ratings read more